KRAS and pancreatic adenocarcinoma: To determine the clinical relevance of our findings from mice, we analyzed the genomic data of 1034 pancreatic adenocarcinoma samples deposited in ICGC, QCMG, UTSW and TCGA databases with cBioPortal for KRAS, TP53 and RNF43 alterations.